Abstract A101: Barriers to cancer care access in Puerto Rico: Exploring clinical and sociodemographic disparities

Abstract INTRODUCTION: In 2020, Puerto Rico (PR) reported 14,168 new cancer cases and 5,354 cancer-related deaths. Timely access to diagnosis and treatment are crucial for enhancing survival and quality of life among cancer patients. Our study aimed to identify barriers to accessing cancer treatment and explore their association with patients selected clinical and sociodemographic characteristics. METHODS: In this ongoing cross-sectional study, cancer patients aged 21+ years, who received active treatment within the past year and resided in PR, completed an online survey. Accessing cancer treatment was defined as self-reported difficulties to initiate or continue cancer treatment. Data were analyzed using descriptive statistics. Contingency tables were generated to assess the relationship of access to cancer treatment and selected characteristics using the Chi-Square test. RESULTS: As of May 16, 2024, a total of 318 participants were eligible and completed the online survey. Most of the participants were women (71.1%), unemployed (68.6%), lived in urban/suburban areas (69.6%), and have multimorbidity (72.3%). The mean age was 58.8±12.6 years. Approximately 30.5% of the participants experienced at least one barrier to accessing cancer treatment, with the most common barriers including health insurance problems (43.3%), lack of communication with healthcare providers (20.6%), and financial problems (24.7%). Barriers to accessing cancer treatment were more likely to occur among women (34.5% vs.20.6%; p=0.02), and those with multimorbidity (33.9% vs.21.6%; p=0.03) than among their counterparts. Furthermore, barriers to accessing cancer treatment were observed mainly among those with lower cancer stages (localized:28.4%, regional:42.9%, distant:22.6%; p<0.05). CONCLUSION: In PR, cancer patients facing challenges in accessing treatment are primarily affected by health insurance problems, lack of communication, and financial issues, which underscores the need for comprehensive support. Further studies should evaluate the experiences of cancer patients when seeking treatment and develop targeted cancer care plans to address these specific concerns effectively. IRB: This project was approved by the Institutional Review Board of the University of Puerto Rico Comprehensive Cancer Center (IRB # 2023-11-123). Citation Format: Lorena González-Sepúlveda, Sofía Contreras-Fernández, Karina Torres-Mojica, Rocío Del Mar Avilés-Mercado, Juan Paulo González-Mayoral, Nancy Cardona-Cordero, Marievelisse Soto-Salgado. Barriers to cancer care access in Puerto Rico: Exploring clinical and sociodemographic disparities [abstract]. In: Proceedings of the 17th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved; 2024 Sep 21-24; Los Angeles, CA. Philadelphia (PA): AACR; Cancer Epidemiol Biomarkers Prev 2024;33(9 Suppl):Abstract nr A101.

Authors

Institutions

Publication Details

Journal
Cancer Epidemiology Biomarkers & Prevention
Published
2024-09-21
DOI
https://doi.org/10.1158/1538-7755.disp24-a101
Primary Topic
Economic and Financial Impacts of Cancer
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Abstract A101: Barriers to cancer care access in Puerto Rico: Exploring clinical and sociodemographic disparities

Lorena González‐Sepúlveda, Marievelisse Soto‐Salgado, Nancy R. Cardona-Cordero, Karina Torres-Mojica et al.
Cancer Epidemiology Biomarkers & Prevention
Economic and Financial Impacts of Cancer
article

Abstract A101: Barriers to cancer care access in Puerto Rico: Exploring clinical and sociodemographic disparities

Lorena González‐Sepúlveda, Marievelisse Soto‐Salgado, Nancy R. Cardona-Cordero, Karina Torres-Mojica, Sofía Contreras-Fernández, Juan Paulo González-Mayoral, Rocío del Mar. Avilés-Mercado
article en

Abstract

Abstract INTRODUCTION: In 2020, Puerto Rico (PR) reported 14,168 new cancer cases and 5,354 cancer-related deaths. Timely access to diagnosis and treatment are crucial for enhancing survival and quality of life among cancer patients. Our study aimed to identify barriers to accessing cancer treatment and explore their association with patients selected clinical and sociodemographic characteristics. METHODS: In this ongoing cross-sectional study, cancer patients aged 21+ years, who received active treatment within the past year and resided in PR, completed an online survey. Accessing cancer treatment was defined as self-reported difficulties to initiate or continue cancer treatment. Data were analyzed using descriptive statistics. Contingency tables were generated to assess the relationship of access to cancer treatment and selected characteristics using the Chi-Square test. RESULTS: As of May 16, 2024, a total of 318 participants were eligible and completed the online survey. Most of the participants were women (71.1%), unemployed (68.6%), lived in urban/suburban areas (69.6%), and have multimorbidity (72.3%). The mean age was 58.8±12.6 years. Approximately 30.5% of the participants experienced at least one barrier to accessing cancer treatment, with the most common barriers including health insurance problems (43.3%), lack of communication with healthcare providers (20.6%), and financial problems (24.7%). Barriers to accessing cancer treatment were more likely to occur among women (34.5% vs.20.6%; p=0.02), and those with multimorbidity (33.9% vs.21.6%; p=0.03) than among their counterparts. Furthermore, barriers to accessing cancer treatment were observed mainly among those with lower cancer stages (localized:28.4%, regional:42.9%, distant:22.6%; p<0.05). CONCLUSION: In PR, cancer patients facing challenges in accessing treatment are primarily affected by health insurance problems, lack of communication, and financial issues, which underscores the need for comprehensive support. Further studies should evaluate the experiences of cancer patients when seeking treatment and develop targeted cancer care plans to address these specific concerns effectively. IRB: This project was approved by the Institutional Review Board of the University of Puerto Rico Comprehensive Cancer Center (IRB # 2023-11-123). Citation Format: Lorena González-Sepúlveda, Sofía Contreras-Fernández, Karina Torres-Mojica, Rocío Del Mar Avilés-Mercado, Juan Paulo González-Mayoral, Nancy Cardona-Cordero, Marievelisse Soto-Salgado. Barriers to cancer care access in Puerto Rico: Exploring clinical and sociodemographic disparities [abstract]. In: Proceedings of the 17th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved; 2024 Sep 21-24; Los Angeles, CA. Philadelphia (PA): AACR; Cancer Epidemiol Biomarkers Prev 2024;33(9 Suppl):Abstract nr A101.

Cancer Epidemiology Biomarkers & PreventionVol. 33(9_Supplement)
University of Puerto Rico System (PR)
Openalex Percentile: Top 80%
Economic and Financial Impacts of Cancer
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.